Accumulating data support the hypothesis that reactive oxygen species (ROS) play a critical role in the vascular complications observed in diabetes. However, the mechanisms of ROS-mediated vascular complications in diabetes are not clear. Here, we tested the hypothesis that ROS-mediated increase in pro-apoptotic factor bax expression leads to medial smooth muscle cell (SMC) apoptosis which is associated with neointima formation.
Introduction
Type 2 diabetes is the most critical risk factor for all patients with coronary artery disease.
The pathophysiology is associated with increased vascular proliferative response in the diabetic patients and is characterized by late morbidity and mortality (21) . Functional derangement of vascular SMCs as a manifestation of cardiovascular complications of diabetes has been observed (1, 32, 38) . During the past few years, convincing evidence has emerged indicating that increased oxidative stress plays a significant role in the pathogenesis of vascular complications associated with type 2 diabetes (37) . Indeed, type 2 diabetes is characterized by increased oxidative stress (39). It is postulated that glucose is prone to oxidation to generate ROS which may cause increased peroxidation (43) .
The hyperglycemia and increased fatty acids in the blood stream observed in type 2 diabetes can cause oxidative stress and damage to the mitochondrial membrane (7) .
Systemic antioxidant therapy with probucol has been shown to reduce intima formation and restenosis after vascular injury (27) . However, a limitation of most of the antioxidants used so far, including probucol, has been the need to administer the drug for 2-4 weeks before angioplasty to demonstrate its beneficial effect in reducing neointima formation (9, 27) . Therefore, we examined the effects of the SOD-mimetic membrane permeable tempol (4-hydroxy tempo, Sigma) administered one day before surgery and continued during the entire experimental period. This low molecular weight cyclic nitroxide acts in a catalytic fashion and is regenerated in the process of quenching superoxide. It has been FINAL ACCEPTED VERSION H-01071-2004.R2 shown to reduce oxidative stress-mediated injury during ischemia/reperfusion (10) and inflammation (18) .
Emerging evidence suggests that increased ROS production leads to vascular SMC apoptosis following injury (24) . Apoptosis is a highly regulated cell deletion process characterized by cellular and nuclear fragmentation. SMC apoptosis associated with significant intimal hyperplasia has been observed in several models of vascular injury (13, 15, 25, 31, 36) . In animal models of balloon vascular injury, marked superoxide production and massive apoptosis of medial smooth muscle cells was observed within the first hour resulting in loss of cell density in the medial layer (30) . Apoptosis of medial smooth muscle cells precedes neointima formation suggesting that cell death of medial SMCs may trigger cell migration and proliferation to form neointima (25) .
Although signal transduction pathways involved in redox-linked VSM cell apoptosis are poorly defined, recent evidence suggests that Bcl-family genes may play a crucial regulatory role. Pro-apoptotic Bcl family members such as bax and bak cause induction of apoptosis disrupting outer mitochondrial membrane integrity (19, 42) . On the other hand, anti-apoptotic members such as Bcl-2 and Bcl-xL prevent apoptosis by heterodimerization with bax and bak, thus preventing outer mitochondrial membrane disruption (3, 44) . Given the link between increased ROS and medial smooth muscle cell apoptosis and emerging evidence that bax may play a role in apoptosis, we hypothesized that antioxidant therapy with tempol would inhibit medial smooth muscle cell apoptosis and neointima formation in balloon-injured rat carotid arteries by inhibiting bax induction. To test this hypothesis, we
examined the effects of antioxidant tempol in balloon-injury induced expression of bax on medial smooth muscle cell apoptosis and neointima formation in rats. These findings provide further evidence for the role of ROS in the pathogenesis of neointima formation after vascular injury. These data suggest that inhibition of redox-sensitive signaling pathways by tempol may represent an important therapeutic approach in the treatment of vascular proliferative diseases in diabetes.
Materials and Methods: Animals
All experiments were performed within the guidelines of the National Institute of Health
Guide for the Care and Use of Laboratory Animals, and all protocols were approved by the Animal Care and Use Committee at The University of Iowa. Adult male SpragueDawley rats weighing 300-325 g were used for this study. Animals were housed in a room with 12 h light /12 h dark cycle and an ambient temperature at 22 0 C. Animals were fed a fructose-rich diet (60%) (Harlan) for 30 days before the surgery to induce type 2 diabetes as has been described earlier (14, 16) .
Plasma Blood Glucose and Insulin Estimation
Blood plasma was collected from non-fasting animals by eye puncture to measure plasma insulin using the ultra sensitive rat insulin ELISA kit (Crystelchem. Inc). Blood glucose was measured with a standardized portable glucometer (ACCU-Check-Roche diagnostics).
Surgical Procedure and Drug Treatment Protocol
Catheter balloon-injury of the left common carotid artery was performed essentially as described previously (8) . In brief, male Sprague-Dawley rats weighing 300-325 g were pre-anesthetized with halothane (Halocarbon, River Edge, NJ) and then anesthetized by intraperitoneal injection of ketamine (10 mg/kg). To produce balloon injury, the bifurcation of the left common carotid artery was exposed through a midline incision, and the left common, and internal carotid arteries temporarily ligated. A 2F embolectomy balloon catheter (Baxter Edwards Lifesciences, CA, USA) was introduced into the isolated common carotid artery through an arteriotomy site in the external carotid artery and advanced to the distal ligation of the common carotid artery. The balloon was inflated with air and drawn toward the arteriotomy 3 times to produce a distending, de-endothelializing injury. After the catheter was withdrawn, the proximal end of external carotid artery was ligated, and blood flow was restored. The surgical incision was closed and the rats were allowed to recover from anesthesia. The right uninjured artery was used as control tissue. Although we (8) and others (5, 23) have used uninjured contralateral artery as a control, it should be kept in mind that a sham procedure in which the control artery is stretched and handled without injury to the endothelium may represent a better control tissue. Animals were allowed free access to water and a fructose-rich diet was given to the experimental group throughout the duration of the experiment. For one group of animals, tempol (1mM), freshly dissolved in drinking water, was administered orally. Tempol administration was initiated 1 day prior to surgery and was continued throughout the experiment.
Tissue Preparation
Fourteen days after angioplasty, animals were anesthetized as described above. The neck and thorax were opened to expose the carotid arteries, the heart and the great vessels. Carotid arteries were fixed by perfusion of 200 ml of saline followed by 500 ml of saline containing 4% paraformaldehyde through a large cannula placed in the left ventricle over a 20-minute period. After perfusion fixation, the right and left carotid arteries were excised, excess periadventitial tissue was trimmed and artery was placed in 4% paraformaldehyde for 48 h before paraffin embedding.
Histomorphometric Measurement
For morphometric analysis, paraffin-embedded sections were used for each of the arterial specimens. Cross sections (6 µm) obtained from uninjured, and injured carotid arteries from control and tempol treated groups and stained with hematoxylin and eosin.
The images were digitized using an Olympus BX 51 microscope (Leeds Precision
Instruments. Inc) and photographs were captured using a Digital Camera. Morphometric analysis of these arterial sections was performed as described earlier (8) . For each arterial cross section, the intimal and medial areas were measured, and the intima/media area ratio was calculated. Morphometric analysis was performed using NIH Image Analysis Software.
In Situ Labeling of Fragmented DNA
Formalin-fixed and paraffin embedded tissue sections were deparaffinized, rehydrated and treated with Proteinase K (20 ug/ml) and endogenous peroxidase activity was 
Immunohistochemistry for Activated Caspase-3 and Bax
To compare and extend the responses estimated by the TUNEL assay, we employed caspase-3 immunohistochemistry for the detection of apoptosis of VSM cells using antibodies that specifically recognize only the large subunit of activated caspase-3 as described previously ( 5, 
Estimation of Smooth Muscle Cell Density in the Media
For the assessment of cellularity, paraffin embedded arterial sections were stained with 
Statistical analysis
Data are expressed as mean ± SEM or mean ± SD. The statistical comparison was performed by one-way analysis of variance (ANOVA) followed by Bonferroni test. A value of P <0.05 was considered significant.
Results
Fructose Rich Diet Increases Plasma Glucose and Insulin Levels. The effects of fructose rich diet on plasma glucose and insulin concentration are shown in (Fig 1) . The glucose levels were significantly higher in animals fed fructose rich diet compared to animals fed normal chow (fructose177 ± 50 vs normal 136 ± 16, mean ± SD , P<0.05, n=18). Although, the insulin levels were higher in animals fed fructose rich diet compared to animals fed normal chow diet they did not reach statistical significance(fructose 4.8 ± 1.4 vs normal 3.9 ± 1.8, mean ± SD, P> o.o5, n=15). It is possible that the variability in glucose and insulin levels is increased because animals were not fasted before collecting blood samples.
Tempol Inhibts Vascular Injury-Induced Increases Apoptosis of Medial Smooth
Muscle Cells. Balloon distension and endothelium denudation injury resulted in an increase in medial smooth muscle cell apoptosis characterized by shrinkage and nuclear condensation visualized by the TUNEL assay that stains nuclei containing nicked DNA, a characteristic signifying the early stages of apoptotic cell death. Quantification of the apoptotic VSM cells in the medial layer showed a significant increase in the apoptotic index in the injured artery compared to the uninjured artery of the diabetic rats (inj 12.9 ± 0.44 vs uninj 2.5 ± 0.18, P<05, n=5) (Fig 2A) . Tempol treatment significantly inhibited apoptosis of the medial SM cells of injured arteries (inj 12.9 ± 0.4 vs inj + tempol 5.2 ± 0.3 %, P< 0.05, n=5) (Fig 2A) .
In ) was significantly decreased after injury (uninj 23.0 ± 2.7 vs inj 10.9 ± 1.5 P< 0.05, n=4) and tempol treatment attenuated injury-induced decrease in medial SMC density (inj 10.9 ± 1.5 vs inj + tempol 18.0 ± 3.0; P< 0.05, n=4) (Fig 3) . 
Bax Expression is

Antioxidant Tempol Inhibits ROS Generation in Injured Arteries:
To verify the effectiveness of oral administration of tempol to attenuate the elevation in superoxide levels in the injured vessel, superoxide levels were estimated by the lucigenin enhanced chemiluminescence method. Injury produced a significant increase in ROS levels in carotid arteries and tempol treatment prevented this increase (Fig 5) . These data show an increase in superoxide levels following vascular injury and tempol treatment can effectively inhibit superoxide levels.
Tempol Treatment Attenuates Neointima Formation in Balloon-Injured Rat Carotid
Artery. Two weeks after injury, a concentric neointimal lesion was found at the site of injury (Fig 6) . The neointima consisted mainly of smooth muscle cells determined by immunostaining for -smooth muscle cell actin. Quantitative analysis of the intimal and medial ratio of pressure-fixed vessel cross sections showed that the ratio was significantly increased (P<0.05) in injured arteries compared to uninjured (uninj 0.12 ± 0.008 vs inj 0.73 ± 0.04) and tempol treatment significantly reduced the neointima/media ratio in injured arteries of diabetic rats (inj 0.73 ± 0.04 vs inj + tempol 0.22 ±0.04, (P<0.05) n=5) (Fig 7) .
Discussion
The possible targets of ROS in VSM cells and their relation to neointima formation in diabetes mellitus have been discussed in a recent review (37) . However, the mechanism by which ROS controls neointima formation remains unclear. Our studies demonstrate that the membrane permeable SOD mimetic tempol is an effective pharmacological compound in inhibiting injury-induced superoxide levels, VSM cell apoptosis and neointima formation at the site of injury. We propose that following vascular injury ROS play a central role in vascular remodeling process and we further speculate that antioxidant therapy may retard injury-induced remodeling of the vessel wall in diabetes.
VSM cell apoptosis plays a critical role in the pathogenesis of a number of cardiovascular diseases (40) . The occurrence of smooth muscle cell apoptosis following balloon angioplasty has been demonstrated in both animal and human models (4, 6, 13, 15, 20, 25) . plays a significant role in intimal hyperplasia in several models of vascular injury and in atherosclerotic lesions (13, 15, 25, 31, 36) . Though a relationship between medial SMC apoptosis and neointima formation has been postulated, a link between medial SMC apoptosis and intimal hyperplasia has been lacking. Next, we examined whether inhibition of medial SMC apoptosis would increase medial SMC density. Our results demonstrate that tempol treatment prevents the loss of medial SMC density (Fig 3) which is associated with the inhibition of neointima formation (Figs 6 and 7 ). How tempol increases medial SMC density is not clear at this time. It is possible that tempol may inhibit the initial loss of medial SMC in response to injury. Alternatively, tempol may regulate proliferation of the remaining medial smooth muscle cells. Further studies are needed to examine the effect of tempol on the dynamics of medial SMC apoptosis and proliferation at different time intervals immediately following injury. Although there was an association between the extent of medial SMC apoptosis and the extent of neointima formation, we have not demonstrated a cause and effect relationship between these two events in this study. It is likely that tempol may be inhibiting neointima formation by mechanisms independent of inhibiting SMC apoptosis. ROS has been shown to increase SMC growth and migration (11, 26, 35) . It is likely that tempol may be inhibiting neointima formation by inhibiting SMC migration and proliferation. Future studies using alternate methods to inhibit medial SMC apoptosis and testing its effects on neointima formation would be required to further elucidate the role of medial SMC apoptosis in neointima formation.
The loss of medial smooth muscle cells due to apoptosis coincided with intimal hyperplasia. Thus, the intima/media ratio in the injured rats was 0.73 ± 0.04 and was reduced to 0.22 ± 0.04 in Tempol-treated animals. Morphometric examination two weeks after vascular injury showed that inhibition of medial smooth muscle cell apoptosis by tempol treatment of diabetic rats correlated with reduced neointima formation compared to untreated rats (Fig 7) . These data confirm the previous observations showing antioxidants inhibit neointima formation following injury (31) . Further, our data suggest that the medial smooth muscle cell apoptotic index and a decreased medial SMC density both have a bearing on the extent of neointima formation. We hypothesize that apoptotic cells send a message to healthy cells to differentiate leading to cell migration and proliferation. Thus, antioxidant tempol therapy, by maintaining medial SMC density after vascular injury, may minimize the stimulus for healthy cells to migrate and proliferate. We have previously demonstrated that MMP-9 expression is regulated by intracellular redox state of VSM cells (12) . Therefore, it is conceivable that injury-induced ROS generation may increase MMP-9 induction and perturbations in cell-matrix interactions may result in increased VSM cell apoptosis. The inhibition of oxidative stress by tempol treatment will attenuate this cellular pathway. Thus, it will be of interest to determine the induction of MMP-9 following injury and the effect of ROS inhibition on this signaling pathway. We postulate that inhibition of MMP-9 induction at the time of injury may prevent early inhibition of medial SMC apoptosis, leading to subsequent decrease in neointimal hyperplasia.
In conclusion, in vivo treatment of diabetic rats with the antioxidant agent tempol inhibits the induction in apoptosis of medial smooth muscle cell and prevents the loss of medial SMC density with its concomitant inhibition of neointima formation. These data would suggest that antioxidant therapy with tempol may prove beneficial to attenuate injuryinduced vascular wall remodeling in diabetes. Representative histological sections of pressure perfused carotid artery taken at 14 days after performing balloon catheter injury and stained with haematoxylin and eosin.
Representative photograph of uninjured (A), injured (B) and injured artery of tempol treated rats (C). Injury resulted in development of neointima formation and tempol treatment inhibited neointima formation. 
